2552.HK · HUA MEDICINE-B
Hong Kong · RS rating 8 · As of 2026-10-14
| Price | 2.09 HKD |
|---|---|
| 1-day change | -0.9% |
| RS rating (overall / 1M / 3M / 12M) | 8 / 17 / 12 / 15 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 15 / 13 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +56.8% |
| Market cap (USD) | $283.8M |